Literature DB >> 13496116

Studies on human infection with Pasteurella tularensis; comparison of streptomycin and chloramphenicol in the prophylaxis of clinical disease.

F R McCRUMB, M J SNYDER, T E WOODWARD.   

Abstract

Entities:  

Keywords:  CHLORAMPHENICOL/therapeutic use; STREPTOMYCIN/therapeutic use; TULAREMIA/prevention and control

Mesh：

Substances：

Year:  1957        PMID： 13496116

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN： 0066-9458


× No keyword cloud information.
  12 in total

1.  Agar gel precipitin analyses in laboratory-acquired tularemia.

Authors:  K L VOSTI; M K WARD; W D TIGERTT
Journal:  J Clin Invest       Date:  1962-07       Impact factor: 14.808

2.  AEROSOL INFECTION OF MAN WITH PASTEURELLA TULARENSIS.

Authors:  F R McCrumb
Journal:  Bacteriol Rev       Date:  1961-09

3.  Experimental tularemia in Macaca mulatta: relationship of aerosol particle size to the infectivity of airborne Pasteurella tularensis.

Authors:  W C Day; R F Berendt
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

4.  Antibiotic prophylaxis and therapy of airborne tularemia.

Authors:  W D Sawyer; H G Dangerfield; A L Hogge; D Crozier
Journal:  Bacteriol Rev       Date:  1966-09

5.  Respiratory antibody to Francisella tularensis in man.

Authors:  E L Buescher; J A Bellanti
Journal:  Bacteriol Rev       Date:  1966-09

6.  The pathology of untreated and antibiotic-treated experimental tularaemia in monkeys.

Authors:  A Baskerville; P Hambleton; A B Dowsett
Journal:  Br J Exp Pathol       Date:  1978-12

7.  B1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses.

Authors:  Deborah D Crane; Amanda J Griffin; Tara D Wehrly; Catharine M Bosio
Journal:  J Immunol       Date:  2013-02-01       Impact factor: 5.422

8.  Lipids derived from virulent Francisella tularensis broadly inhibit pulmonary inflammation via toll-like receptor 2 and peroxisome proliferator-activated receptor α.

Authors:  Deborah D Crane; Robin Ireland; Joshua B Alinger; Pamela Small; Catharine M Bosio
Journal:  Clin Vaccine Immunol       Date:  2013-08-07

9.  Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia.

Authors:  Deborah D Crane; Dana P Scott; Catharine M Bosio
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

10.  Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination.

Authors:  Dedeke Rockx-Brouwer; Audrey Chong; Tara D Wehrly; Robert Child; Deborah D Crane; Jean Celli; Catharine M Bosio
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.